What were the most common cancers at GCRI in late 2025?

Mouth and breast cancers were the most common, making up 20% of all patient admissions at GCRI from January to November 2025.

How has cancer treatment improved at GCRI?

Improved public awareness, new technologies, and advanced tools enable earlier diagnoses and better treatment outcomes, including faster recovery and tissue preservation.

What is the importance of early diagnosis in cancer treatment?

Early diagnosis and intervention are crucial, as they improve treatment options and overall outcomes for cancer patients.

Home / Health / GCRI Sees More Early Cancer Diagnoses: New Tech Aids Treatment

GCRI Sees More Early Cancer Diagnoses: New Tech Aids Treatment

4 Feb

•

Summary

Mouth and breast cancers were 20% of GCRI admissions in late 2025.
GCRI saw 1,931 men for mouth and 1,456 women for breast cancer.
New technologies and awareness lead to earlier diagnoses and better outcomes.

GCRI Sees More Early Cancer Diagnoses: New Tech Aids Treatment

From January to November 2025, mouth and breast cancers accounted for one in every five admissions at the Gujarat Cancer Research Institute (GCRI). The institute admitted 16,794 patients, with 1,931 men diagnosed with mouth cancer and 1,456 women with breast cancer. This period saw significant advancements in patient care and awareness.

GCRI director Dr. Shashank Pandya highlighted a shift in patient approach, noting more individuals seeking help at earlier stages. This rise in awareness, coupled with new diagnostic and treatment technologies, has improved oncologists' ability to achieve better recovery outcomes and preserve tissues. The institute also reported conducting 50 robotic surgeries in the past six months and introduced hyperthermic intraperitoneal chemotherapy (HIPAC) for abdominal cancers.